Search Warning Letters

Tuesday, October 30, 2007

A La Carte Foods, Inc. 30-Oct-07

Department of Health and Human Services' logoDepartment of Health and Human Services

Public Health Service
Food and Drug Administration

 

New Orleans District
404 BNA Drive
Building 200 - Suite 500
Nashville, TN 37217

Telephone: (615) 366-7801
FAX: (615) 366-7802


 

October 30, 2007

WARNING LETTER NO. 2007-NOL-03

FEDERAL EXPRESS
OVERNIGHT DELIVERY

Darrel J . Rivere, Owner
A La Carte Foods, Inc.
278 Ideal Street
Paincourtville, Louisiana 70391

Dear Mr. Rivere:

We inspected your seafood processing facility, located at 278 Ideal Street, Paincourtville, Louisiana on July 24 - 26, 2007 . We found you have serious violations of the seafood Hazard Analysis and Critical Control Point (HACCP) regulation, Title 21, Code of Federal Regulations (21 CFR), Part 123, and the Current Good Manufacturing Practice (CGMP) regulation for foods, 21 CFR 110. In accordance with 21 CFR 123.6(g), failure of a processor of fish or fishery products to have and implement a HACCP plan, complying with this section or otherwise operate in accordance with the requirements of Part 123, renders the fish or fishery products adulterated within the meaning of Section 402(a)(4) of the Federal Food, Drug, and Cosmetic Act (the Act), [21 United States Code (USC) 342(a)(4)]. Accordingly, your "Not Fully Cooked and Not Shelf Stable", "Heat Treated but not Shelf Stable", and your "Heat Treated but Not Fully Cooked-Not Shelf Stable" seafood products are adulterated, because they have been prepared, packed, or held under insanitary conditions whereby they may have been rendered injurious to health. You may find the Act, the seafood HACCP regulation and the Fish and Fisheries Product Hazards & Controls Guidance through links in FDA's Internet home page at www. fda.gov.

Your significant violations were as follows:

1. You must conduct a hazard analysis to determine whether there are food safety hazards which are reasonably likely to occur and have a HACCP plan which, at a minimum, lists the critical control points, to comply with 21 CFR 123.6(a) and (c)(2). A critical control point is defined in 21 CFR 123.3(b) as a "point, step, or procedure in a food process at which control can be applied and a food safety hazard can as a result be prevented, eliminated, or reduced to acceptable levels." However, your firm's HACCP plan for products "Not Fully Cooked and Not Shelf Stable", which includes crab cakes and crab kickers, and your HACCP plan for products "Heat Treated but Not Fully Cooked-Not Shelf Stable," which includes crabmeat au gratin, do not list the critical control point of refrigerated storage of cooked seafood ingredients for controlling the food safety hazard of pathogen growth and toxin formation. The hazard of pathogen growth and toxin formation is associated with pasteurized canned crabmeat, an ingredient of some of the products manufactured under these HACCP plans. FDA recommends implementing controls which assure the product has not been exposed to temperatures above 40°F while in storage. These recommendations include monitoring the adequacy of the ice surrounding the product or continuous temperature monitoring of ambient temperature to control the growth of pathogens and toxin formation in cooked seafood products.

2. You must have a HACCP plan which, at a minimum, lists monitoring procedures and their frequency for each critical control point, to comply with 21 CFR 123 .6 (c) (4). However, all your firm's HACCP plans for products "Heat Treated but Not Fully Cooked", "Heat Treated but not Shelf Stable" and "Not Fully Cooked-Not Shelf Stable" list a monitoring procedure of "Temperature in each box", at receipt of refrigerated, cooked seafood products which is not adequate to control the hazard of pathogen growth and toxin formation during transit. FDA recommends implementing controls which assure the product has not been exposed to unsafe conditions while in transit. These recommendations include monitoring the adequacy of the ice surrounding the product or continuous temperature monitoring of ambient temperature during transit to control the growth of pathogens and toxin formation in cooked seafood products.

3. You must have a HACCP plan which, at a minimum, lists the critical limits which must be met, to comply with 21 CFR 123.6(c)(3). A critical limit is defined in 21 CFR 123 .3(c) as "the maximum or minimum value to which a physical, biological, or chemical parameter must be controlled at a critical control point to prevent, eliminate, or reduce to an acceptable level the occurrence of the identified food safety hazard." However, your firm's HACCP plans for multiple types of cooked seafood products list critical limits "[redacted] degrees F", "[redacted] degrees F", and "[redacted] degrees F" which are not adequate to control the hazard of pathogen survival through cooking. There is no indication as to whether these temperatures represent product temperatures (i.e. internal) or temperatures of the cooking apparatus. Furthermore, there is no "time" component listed in conjunction with the critical temperature limits. Please be advised when monitoring internal end-product temperatures, the Fish and Fisheries Products Hazards and Controls Guidance: 3rd Edition recommends employing a process authority to validate a process schedule to assure you are controlling the hazard of pathogen survival through processing and to ensure each piece in each batch receives an adequate cook process.

We may take further action if you do not promptly correct these violations. For instance, we may seize your products and/or enjoin your firm from operating.

Please respond in writing within fifteen (15) working days from your receipt of this letter outlining the specific things you are doing to correct these violations. You should include in your response documentation, such as HACCP and verification records, or other useful information which would assist us in evaluating your corrections. If you cannot complete all corrections before you respond, state the reason for your delay and when you will correct any remaining violations.

We noted you have a HACCP plan for products which are not fully cooked and are not shelf stable. Please be advised FDA recommends manufacturers provide a cook adequate to control the pathogen(s) of concern to their products if the product might reasonably be consumed without a thorough cooking by the end user.

This letter may not list all the violations at your facility. You are responsible for ensuring your processing plant operates in compliance with the Act, the seafood HACCP regulation (21 CFR 123) and CGMP regulation (21 CFR 110). You also have a responsibility to use procedures to prevent further violations of the Act and all applicable regulations.

Please send your reply to the U.S. Food and Drug Administration, Attention: Karl L. Batey, Compliance Officer, at the above address. If you have questions regarding any issues in this letter, please contact Ms. Batey at (615) 366-7808.

Sincerely,

/S/

H. Tylhornburg
District Director
New Orleans District

Enclosure: Form FDA 483

 

-

Tuesday, October 9, 2007

4 D Cattle 09-Oct-07

Department of Health and Human Services' logoDepartment of Health and Human Services

Public Health Service
Food and Drug Administration

 

Denver District Office
Bldg. 20-Denver Federal Center
P.O. Box 2508 7
6th Avenue & Kipling Street
Denver, Colorado80225-0087
Telephone: 303-236-3000
FAX: 303-236-3100


 

October 9, 2007

WARNING LETTER

CERTIFIED MAIL
RETURN RECEIPT REQUESTED

Mr. Dennis D. Luce
Owner
4 D Cattle
Route 1, Box 98
Fort Sumner, NM 88119
 

Ref. #: DEN-08-03

Dear Mr. Luce:

An investigation of your dairy operation located at 1262 Lande View Road, Fort. Sumner,, New Mexico, conducted by a representative of the U.S. Food and Drug Administration (FDA) on May 31 - June 2, 2007, confirmed that you offered an animal for sale for slaughter as food that was adulterated under sections 402(a)(2)(C)(ii) [21 U.S.C. § 342 (a)(2)(C)(ii)] and 402(a)(4) [21 U.S.C. § 342 (a)(4)] of the Federal Food, Drug, and Cosmetic Act (the Act) . The inspection also revealed that you caused the new animal drugs Tilmicosin and Phenylbutazone to become adulterated within the meaning of section 501(a)(5) of the Act [21 U.S.C. § 351(a)(5)] and unsafe under section 512 of the Act [21 U.S.C. § 360b]. You can find the Act and its associated regulations on the Internet through links on the FDA's web page at www.fda.gov.

On January 10, 2007, you sold a Holstein steer, identified with back tag [redacted] for slaughter as food to [redacted]. This animal was slaughtered by [redacted] United States Department of Agriculture, Food Safety and Inspection Service (USDA/FSIS) analysis of tissue samples collected from that animal identified the presence of 18.6 parts per million (ppm) Tilmicosin in the liver tissue, and 7.5 ppm Tilmicosin in the muscle tissue. In addition, the USDA/FSIS analysis identified 8888 ppm Phenylbutazone in the kidney tissue.

A tolerance of 1.2 ppm has been established for residues of Tilmicosin in the liver tissue of cattle, and 0.1 ppm in cattle muscle tissue, as codified in Title 21, Code of Federal Regulations, Section 556.735, (21 CFR 556.735). The presence of this drug in the edible tissues of this animal in amounts exceeding the tolerance set out in 21 CFR 556.735 causes the food to be adulterated within the meaning of section 402(a)(2)(C)(ii) of the Act [21 U.S.C. § 342(a)(2)(C)(ii)].

No tolerance has been established for residues of Phenylbutazone in edible tissues of cattle. Phenylbutazone injection is only approved for use in dogs and horses, as set out in 21 CFR 522.1720. The presence of this drug in the edible tissues of this animal causes the food to be adulterated within the meaning of section 402(a)(2)(C)(ii) of the Act [21 U.S.C. § 342(a)(2)(C)(ii)].

Our investigation also found that you hold animals under conditions that are so inadequate that medicated animals bearing potentially harmful drug residues are likely to enter the food supply. You lack an adequate system to ensure that animals medicated by you have been withheld from slaughter for appropriate periods of time to permit depletion of potentially hazardous residues of drugs from edible tissues. For example, you failed to maintain and review complete treatment records, and you lack an adequate inventory system for determining the quantities of drugs used to medicate your animals. Food from animals held under such conditions is adulterated within the meaning of section 402(a)(4) of the Act [21 U.S.C. § 342(a)(4)].

In addition, you adulterated Tilmicosin and Phenylbutazone within the meaning of section 501(a)(5) [21 U.S.C. § 351 (a)(5)] of the Act when you failed to use the drugs in conformance with their approved labeling. "Extra-label use," i.e., the actual or intended use of a drug in an animal in a manner that is not in accordance with the approved labeling, is only permitted if the use is by or on the lawful order of a licensed veterinarian within the context of a valid veterinarian/client/patient relationship. The extra-label use of approved .veterinary or human drugs must comply with sections 512(a)(4)and (5) of the Act [21 U.S.C. §§ 360b(a)(4), (5)] and 21 C.F.R. Part 530.

For example, you administered Tilmicosin without-following the withdrawal period set forth in the approved labeling and you did so without the supervision of a licensed veterinarian, in violation of 21 C.F.R. 530.11(a). In addition, you administered Phenylbutazone to a species not approved on the labeling. Furthermore, your extra-label use resulted in illegal drug residues, in violation of 21 C.F.R. 530.11(c). Because your extra-label use of these drugs did not comply with 21 CFR Part 530, the drugs were unsafe under section 512(a) of the Act [21 U.S.C. § 360b(a)], and your use caused them to be adulterated within the meaning of section 501(a)(5) of the Act [21 U.S.C. § 351(a)(5)]. The above is not intended to be an all-inclusive list of violations. As a producer of animals offered for use as food, you are responsible for ensuring that your overall operation and the foods you distribute are in compliance with the law.

You should take prompt action to correct the above violations and to establish procedures whereby such violations do not recur. Failure to do so may result in regulatory action without further notice such as seizure and/or injunction.

You should notify this office in writing of the steps you have taken to bring your firm into compliance with the law within fifteen (15) working days of receiving this letter. Your response should include each step that has been taken or will be taken to correct the violations and prevent their recurrence. If corrective action cannot be completed within fifteen (15) working days, state the reason for the delay and the time frame within which the corrections will be completed. Please include with your response copies of any documentation demonstrating that corrections have been made.

Your response should be sent to U.S. Food and Drug Administration, P.O. Box 25087, Denver, Colorado 80225-0087, Attention: William H. Sherer, Compliance Officer. If you have any questions about this letter, please contact Mr . Sherer at (303) 236-3051.

Sincerely,

/S/

B. Belinda Collins
Denver District Director
 

cc:
Ronald K. Jones, D.V.M.
Denver District Manager
USDA/FSIS
PO Box 25387
DFC, Bldg 45
Denver, CO 80225

I. Miley Gonzalez, Ph.D.
Secretary
New Mexico Department of Agriculture
New Mexico State University
P.O. Box 300005, MSC 3189
Las Cruces, NM 88003-8005

Lee C. Jan, D.V.M.
Director
Texas Department of Health
Meat Safety Assurance Unit
1100 West 49th Street
Austin, TX 78756-7466
 

-